Shanghai Xuerong Biotechnology Co., Ltd. (SHE:300511)

China · Delayed Price · Currency is CNY

5.15

+0.11 (2.18%)

At close: Jul 31, 2026

SHE:300511 Financials Overview

Financials in millions CNY. Fiscal year is January - December.

Millions CNY. Fiscal year is Jan - Dec.

Revenue & Profits

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar '26 Mar 31, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Jan '23 Jan 1, 2023	Jan '22 Jan 1, 2022
Revenue	2,226	1,988	2,162	2,565	2,320	2,073
Revenue Growth	11.34%	-8.09%	-15.70%	10.55%	11.93%	-5.86%
Gross Profit	416.78	254.57	33.76	156.48	218.31	49.16
Operating Income	236.01	71.55	-161.54	-114.23	53.48	-134.14
Net Income	195.72	29.79	-617.07	-188.06	-287.23	-311.59
Earnings Per Share	0.34	0.05	-1.24	-0.38	-0.59	-0.72
EPS Growth	-	-	-	-	-	-

Revenue by Segment

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Jan '23 Jan 1, 2023	Jan '22 Jan 1, 2022
Edible Mushroom Industry	1,966	2,133	2,534	2,291	2,037
Unallocated Other Business	21.87	29.86	30.84	29.29	-
Total	1,988	2,162	2,565	2,320	2,073

Cash & Debt

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar '26 Mar 31, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Jan '23 Jan 1, 2023	Jan '22 Jan 1, 2022
Cash & Investments	297.51	161.45	167.95	252.72	633.82	340.77
Total Debt	1,123	1,290	2,148	2,181	1,744	2,005
Net Cash (Debt)	-825.73	-1,129	-1,980	-1,928	-1,111	-1,664
Net Cash Growth	-	-	-	-	-	-
Net Cash Per Share	-1.44	-1.89	-3.98	-3.90	-2.28	-3.85

Cash Flow & CapEx

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar '26 Mar 31, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Jan '23 Jan 1, 2023	Jan '22 Jan 1, 2022
Operating Cash Flow	533.37	415.85	437.2	357.84	367.13	244.06
Capital Expenditures	-131.02	-79.59	-327.46	-1,097	-319.47	-637.19
Free Cash Flow	402.35	336.26	109.74	-739.19	47.66	-393.13
Free Cash Flow Growth	25.66%	206.40%	-	-	-	-

Margins

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar '26 Mar 31, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Jan '23 Jan 1, 2023	Jan '22 Jan 1, 2022
Gross Margin	18.73%	12.81%	1.56%	6.10%	9.41%	2.37%
Operating Margin	10.60%	3.60%	-7.47%	-4.45%	2.31%	-6.47%
Pretax Margin	9.10%	1.97%	-28.50%	-7.49%	-16.40%	-17.16%
Profit Margin	8.79%	1.50%	-28.54%	-7.33%	-12.38%	-15.03%
FCF Margin	18.08%	16.92%	5.08%	-28.82%	2.05%	-18.96%

Valuation

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Aug '26 Aug 2, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Jan '23 Jan 1, 2023	Jan '22 Jan 1, 2022
PE Ratio	15.13	134.22	-	-	-	-
Forward PE	-	8.61	8.61	13.05	7.90	8.42
P/FCF Ratio	8.20	11.89	15.77	-	68.08	-
PS Ratio	1.48	2.01	0.80	1.04	1.40	1.62